Ledger.Open graph →
SEC Form D · filed February 4, 2021

Exacis Biotherapeutics Inc

Offering
$3.0M
Sold
$50K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Matthew Angel · Cambridge, MADirectorGregory Fiore · Cambridge, MAExecMark Corrigan · Cambridge, MADirectorRegan Bozman · San Francisco, CAExecAndrew A. Tisdale · Providence, RIDirectorLattice Capital II GP LLC · San Francisco, CADirectorMike Jacobellis · New York, NYDirectorScott Radke · New York, NYExecPhilippe Schulligen · Duluth, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗